Ferumoxytol Patent Expiration

Ferumoxytol is Used for treating iron deficiency in patients. It was first introduced by Covis Pharma Gmbh in its drug Feraheme on Jun 30, 2009. 2 different companies have introduced drugs containing Ferumoxytol.


Ferumoxytol Patents

Given below is the list of patents protecting Ferumoxytol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Feraheme US6599498 Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives Mar 08, 2020

(Expired)

Covis
Feraheme US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof Mar 08, 2020

(Expired)

Covis
Feraheme US7871597 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Covis
Feraheme US8501158 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Covis
Feraheme US8591864 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Covis
Feraheme US8926947 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents Mar 08, 2020

(Expired)

Covis


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Ferumoxytol Generics

Only one generic application has been filed for Ferumoxytol.

Given below is the list of companies who have filed for Ferumoxytol generic.


1. SANDOZ

Sandoz Inc has filed for 1 generic for Ferumoxytol. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 510MG IRON/17ML (EQ 30MG IRON/ML) solution Prescription INTRAVENOUS AB Jan 15, 2021